Martin Andreas, Haran Burri, Fabien Praz, Osama Soliman, Luigi Badano, Manuel Barreiro, João L Cavalcante, Tom de Potter, Torsten Doenst, Kai Friedrichs, Jörg Hausleiter, Nicole Karam, Susheel Kodali, Azeem Latib, Eloi Marijon, Suneet Mittal, Georg Nickenig, Aldo Rinaldi, Piotr Rudzinski, Marco Russo, Christoph Starck, Ralph Stephan von Bardeleben, Nina Wunderlich, José Luis Zamorano, Rebecca T Hahn, Francesco Maisano, Christophe Leclercq
The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs...
February 1, 2024: European Heart Journal